Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-25

Clinical Trial Update: Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating how genetic factors influence erectile dysfunction severity and tadalafil response in men with diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Erectile Dysfunction With Diabetes Mellitus | Phase 3 | Status: RECRUITING